| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |